What are the symptoms of Guillain-Barré syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Symptoms of Guillain-Barré Syndrome

Guillain-Barré syndrome (GBS) classically presents with rapidly progressive bilateral ascending weakness starting in the legs, accompanied by distal paresthesias or sensory loss, and decreased or absent reflexes—this triad should immediately raise suspicion for GBS. 1

Classic Presentation

The hallmark clinical features include:

Motor Symptoms

  • Bilateral weakness that begins in the legs and ascends to involve the arms and cranial muscles
  • Weakness progresses rapidly, with most patients reaching maximum disability within 2 weeks of onset 1
  • Reflexes are decreased or absent at presentation in most patients, and nearly universal at disease nadir 1

Sensory Symptoms

  • Distal paresthesias (tingling, numbness) typically appear first
  • Sensory loss follows or accompanies the weakness
  • These sensory symptoms start distally and progress proximally 1

Autonomic Dysfunction

Dysautonomia is common and includes:

  • Blood pressure instability (fluctuations)
  • Heart rate abnormalities (arrhythmias)
  • Pupillary dysfunction
  • Bowel or bladder dysfunction 1

Pain

Pain is frequently reported and can manifest as:

  • Muscular pain
  • Radicular pain (nerve root distribution)
  • Neuropathic pain 1

Respiratory Involvement

  • Approximately 20% of patients develop respiratory failure requiring mechanical ventilation 1
  • This can occur without preceding dyspnea symptoms, making respiratory monitoring critical 2

Atypical Presentations

Critical pitfall: GBS can present atypically, and failure to recognize these variants causes diagnostic delays, particularly in young children 1.

Asymmetric or Unusual Distribution

  • Weakness may be asymmetrical though always bilateral
  • Can be predominantly proximal or distal
  • May start in arms, legs, or simultaneously in all limbs 1

Pediatric Presentations (Age <6 years)

Children often present with nonspecific features:

  • Poorly localized pain
  • Refusal to bear weight
  • Irritability
  • Meningism
  • Unsteady gait 1

Pain-Predominant Presentation

  • Severe diffuse pain may precede weakness
  • Isolated cranial nerve dysfunction can occur before limb weakness develops 1

Reflex Variations

In pure motor variants (particularly AMAN subtype), reflexes may be:

  • Normal throughout disease course
  • Even exaggerated in some cases 1

Clinical Variants

Miller Fisher Syndrome (MFS)

The classic triad consists of:

  • Ophthalmoplegia (eye movement paralysis)
  • Areflexia (absent reflexes)
  • Ataxia (incoordination) 1

Pure Motor Variant

  • Weakness without sensory signs
  • More common in certain geographic regions 1

Regional Variants

  • Pharyngeal-cervical-brachial weakness: Limited to upper limbs and bulbar muscles
  • Paraparetic variant: Weakness confined to lower limbs
  • Bilateral facial palsy with paresthesias 1

Bulbar Symptoms

  • Difficulty swallowing (dysphagia)
  • Slurred speech (dysarthria)
  • These may appear early or as isolated initial symptoms 3

Temporal Features

Key diagnostic timing:

  • Disease onset is acute or subacute
  • Maximum disability typically reached within 2 weeks 1
  • Red flag: If progression continues beyond 4 weeks or occurs within 24 hours, strongly consider alternative diagnoses (including acute-onset CIDP if progression >8 weeks) 1, 2
  • GBS follows a monophasic course (single episode), though 2-5% experience recurrence 1

Preceding Events

Approximately two-thirds of patients report infection symptoms in the 6 weeks before GBS onset 1. Key triggers include:

  • Campylobacter jejuni (associated with more rapid deterioration and axonal variants) 1, 4
  • Cytomegalovirus
  • Zika virus
  • Mycoplasma pneumoniae
  • Epstein-Barr virus
  • Hepatitis E virus 1

Important caveat: Absence of antecedent illness does not exclude GBS, as triggering infections can be subclinical 1.

References

4
Research

Guillain-Barré Syndrome.

Mayo Clinic proceedings, 2017

Related Questions

What are the clinical manifestations and latest treatment guidelines for Guillain‑Barré syndrome?
In a patient with Guillain‑Barré syndrome who feels feverish, how should fever be evaluated and managed?
How should I manage a patient with suspected atypical Guillain‑Barré syndrome who presents with severe tremor and paresthesias but no ataxia or ophthalmoplegia?
How should suspected Guillain‑Barré syndrome be managed?
Can the patient with suspected Guillain‑Barré syndrome use over‑the‑counter medication or purchase anything without going to the emergency department?
When should the fluconazole loading dose be administered?
How frequently should TSH be measured during pregnancy to assess the response to levothyroxine therapy?
When is the onset of clinical effect of pyridostigmine expected?
What is the appropriate loading dose of voriconazole for an adult patient?
In a patient with alcohol withdrawal, suspected Wernicke encephalopathy, a first generalized tonic‑clonic seizure, and fatty liver, what is the appropriate management plan and medication schedule?
How does heart failure cause impaired gastrointestinal iron absorption?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.